Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
14.36
-0.17 (-1.17%)
At close: May 12, 2025, 4:00 PM
14.36
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Pediatrix Medical Group Market Cap
Pediatrix Medical Group has a market cap or net worth of $1.21 billion as of May 12, 2025. Its market cap has increased by 55.57% in one year.
Market Cap
1.21B
Enterprise Value
1.65B
1-Year Change
55.57%
Ranking
Category
Stock Price
$14.36
Market Cap Chart
Since December 1, 1998, Pediatrix Medical Group's market cap has increased from $834.00M to $1.21B, an increase of 44.99%. That is a compound annual growth rate of 1.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 1.25B | 10.77% |
Dec 31, 2024 | 1.13B | 44.20% |
Dec 29, 2023 | 781.40M | -36.70% |
Dec 30, 2022 | 1.23B | -47.53% |
Dec 31, 2021 | 2.35B | 11.99% |
Dec 31, 2020 | 2.10B | -10.33% |
Dec 31, 2019 | 2.34B | -20.61% |
Dec 31, 2018 | 2.95B | -41.04% |
Dec 29, 2017 | 5.00B | -19.82% |
Dec 30, 2016 | 6.24B | -7.38% |
Dec 31, 2015 | 6.74B | 1.51% |
Dec 31, 2014 | 6.64B | 23.64% |
Dec 31, 2013 | 5.37B | 35.52% |
Dec 31, 2012 | 3.96B | 12.50% |
Dec 30, 2011 | 3.52B | 9.76% |
Dec 31, 2010 | 3.21B | 14.73% |
Dec 31, 2009 | 2.80B | 93.36% |
Dec 31, 2008 | 1.45B | -56.14% |
Dec 31, 2007 | 3.30B | 39.08% |
Dec 29, 2006 | 2.37B | 8.41% |
Dec 30, 2005 | 2.19B | 52.82% |
Dec 31, 2004 | 1.43B | 10.48% |
Dec 31, 2003 | 1.30B | 28.17% |
Dec 31, 2002 | 1.01B | 21.90% |
Dec 31, 2001 | 829.40M | 117.46% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.87B |
Johnson & Johnson | 370.32B |
UnitedHealth Group | 343.41B |
AbbVie | 335.67B |
Novo Nordisk | 292.03B |
Abbott Laboratories | 229.47B |
Novartis AG | 213.30B |
AstraZeneca | 210.42B |